Filter by country
Africa
Sao Tome and Principe
Liberia
Madagascar
Malawi
Mali
Mauritania
Mozambique
Niger
Nigeria
Rwanda
Lesotho
Senegal
Sierra Leone
South Sudan
Tanzania, UR
Togo
Uganda
Zambia
Zimbabwe
Cote d'Ivoire
Benin
Burkina Faso
Burundi
Cameroon
Central African Republic (the)
Chad
Comoros (the)
Congo (the)
Angola
Congo, DR
Eritrea
Ethiopia
The Gambia
Ghana
Guinea-Bissau
Guinea
Kenya
South-East Asia
Bangladesh
Bhutan
China
Korea, DPR
India
Indonesia
Myanmar
Nepal
Sri Lanka
Timor Leste
Americas
Cuba
Haiti
Honduras
Nicaragua
Bolivia
Guyana
Europe
Albania
Armenia
Azerbaijan
Bosnia-Herzegovina
Georgia
Kyrgyzstan
Moldova
Tajikistan
Turkmenistan
Ukraine
Uzbekistan
Western Pacific
Cambodia
Kiribati
Lao PDR
Mongolia
Papua New Guinea
Solomon Islands
Vietnam
Eastern Mediterranean
Afghanistan
Djibouti
Pakistan
Somalia
Sudan (the)
Yemen
Filter by Category
Documents
COVAX documents
Russian
IRC reports
Portuguese
Annual Contributions and Proceeds
Cash Receipts
Advocacy
Resource mobilisation
German
COVID-19 situation report
Spanish
COVAX AMC
Gavi Process Guidelines
Gavi Programme Funding Guidelines
Programme audit
Internal audit
Investigation
Reports to the Board
Other (IA)
COVAX data brief
White papers
AMC Documents
Country Documents
Evaluations
Financial Reports
Guidelines and Forms
Legal
Strategy
Supply and Procurement
Policies
Annual Reports
Gavi Fact Sheets
Gavi Publications
The Evidence Base
Gavi Bulletin
Other Publishers
Board Minutes
Committee minutes
VIS
Audit
News
AMC Updates
Gavi Features
Press Releases
Roi
Statements
Gavi Blogs
Vaccineswork
Theme - Pentavalent
Top stories
3rd donor pledging
3rd donor pledging featured
Partner news
Audio Visual
Infographics
Presentations
Videos
Galleries
Board
Committee
Members

Articles (3451)

Showing 3 of 3451 View All
Showing 1 of 1151 pages

16 May 2023

What is the World Health Assembly and why is it important?

The World Health Assembly takes place annually to discuss the policy and strategy for tackling key global healthcare challenges, and how to resolve them. 

16 May 2023

COVID fatigue: cognitive behavioural therapy could help people manage persistent symptoms – new research

Could CBT, a widely used form of ‘talking therapy’, help people who have persistent fatigue after having COVID? A recent study suggests it could.

16 May 2023

Routine vaccines, extraordinary impact: Pneumococcus

Pneumococcal vaccines have substantially reduced deaths from pneumonia and meningitis, but they don’t protect against all bacterial strains, and antibiotic resistance is a growing threat.

Countries (77)

Showing 3 of 77 View All
Showing 1 of 26 pages

Documents (9031)

Showing 3 of 9031 View All
Showing 1 of 3011 pages

31 December 2023

Early Notice of RFP Opportunities for Gavi Evaluations

The Centralised Evaluation Team (CET) within the Evaluation and Learning Unit (EvLU) at Gavi is responsible for the commissioning and day-to-day management of evaluations, including ensuring the utility, quality and timely delivery of evaluation reports and disseminating the findings. The document provides information on the current pipeline of centralized evaluations to be commissioned in 2023 through future RFPs.

5 June 2023

RFP: Intelligent Maintenance and Planning Tool Software Developer, Solution Provider or Systems Integrator

Gavi is seeking a software developer, solution provider, or systems integrator to take over the hosting and maintenance of IMPT and work with Gavi and CCE manufacturers to integrate countries’ equipment data into the tool. Nexleaf will work with the firm until the end of September 2023 to ensure a smooth transition, with the firm taking over full-time in August 2023.

1 June 2023

RFP: UK Political Consultancy

Gavi Alliance is seeking to engage a public relations agency to help expand Gavi’s footprint in terms of visibility and influence amongst key UK audiences, to advance its mission and assist in establishing critical new relationships within both the political and policymaking arenas as well as among potential private sector donors.

Donor profiles (112)

Showing 3 of 112 View All
Showing 1 of 38 pages

Other(662)

Showing 3 of 662 View All
Showing 1 of 221 pages

May 3, 2023

A preliminary assessment of COVAX’s impact in lower-income countries

Approximately 90% of COVAX-delivered COVID-19 doses have gone to lower-income economies. This represents the fastest and most complex global deployment of vaccines ever. But in terms of achieving equitable access during this pandemic, how…

May 1, 2023

COVAX Facility and COVAX Advance Market Commitment (AMC) Formative Review and Baseline Study

Gavi, the Vaccine Alliance appointed Itad to conduct an evaluability assessment and evaluation design study, and a baseline study of the COVAX Facility and COVAX Advance Market Commitment (AMC).

May 1, 2023

Evaluation of Gavi’s initial response to COVID-19

Gavi, the Vaccine Alliance appointed Euro Health Group (EHG) to conduct an evaluation of Gavi’s initial response to COVID-19.

Subscribe to our newsletter